ROAR-A: Re-optimization Based Online Adaptive Radiotherapy of Anal Cancer
Status: Recruiting
Location: See location...
Intervention Type: Radiation
Study Type: Observational
SUMMARY
A single-arm, prospective, Phase II, single-center clinical trial that will investigate if daily online adaptive radiotherapy for anal cancer will significantly reduce early treatment-related GI toxicity compared with the historically reported rate for non-adaptive intensity modulated radiation therapy (IMRT).
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Biopsy-verified anal cancer
• Eligible for curative intended radiotherapy
• Written and oral consent
Locations
Other Locations
Denmark
Oncology dept, Herlev and Gentofte Hospital
RECRUITING
Herlev
Contact Information
Primary
Eva Serup-Hansen, MD, PhD
eva.serup-hansen@regionh.dk
+4538689084
Backup
katrine S storm, MD
katrine.smedegaard.storm@regionh.dk
+4538686269
Time Frame
Start Date: 2022-01-01
Estimated Completion Date: 2031-01-01
Participants
Target number of participants: 205
Treatments
Online adaptive radiotherapy
Daily online adaptive radiotherapy
Related Therapeutic Areas
Sponsors
Leads: Herlev Hospital